MALAT1 and acute kidney injury: LncRNA MALAT1 targeted by miR-370-3p, thereby inhibiting the expression level of HMGB1 as well as the production of inflammatory factors and, subsequently, alleviating the inflammatory injury of AKI (Figure 4) [72].